About MediPharm Labs
MediPharm Labs is a publicly listed company based in Barrie (Canada) founded in 2016 by Keith Strachan. Pharmaceutical-grade cannabinoid products and APIs are manufactured. The company has 161 employees. MediPharm Labs has completed 1 acquisition, including VIVO Cannabis. MediPharm Labs offers products and services including GMP Cannabis API, Formulated Oils, Capsules, and Vapes. Its focus areas include HealthTech, Cannabis HealthTech and Cannabinoid Research Services. Its legal entity is MEDIPHARM LABS INC. Its competitors include Motif Labs and Biotii Technologies; 1 of its 2 listed competitors has raised funding.
Company details
MediPharm Labs was founded in 2016 in Barrie, Canada, and operates within the pharmaceutical sector. Cannabinoid-based products and active pharmaceutical ingredients are formulated, tested, processed, packaged, and distributed to domestic and international markets. Wholesale products are supplied, while clinical trials and academic partnerships are supported. Extraction and purification methods are employed to produce high-quality cannabinoid derivatives.
- Annual Revenue$32.95 M (USD)7.54as on Dec 31, 2025
- Net Profit-$6.04 M (USD)22.69as on Dec 31, 2025
- EBITDA-$5.1 M (USD)23.31as on Dec 31, 2025
- Latest Funding Round$239.19K (USD), Grant
Aug 2021
- Investorsbusiness.gov.au
& 1 more
- Employee Count161
- Investments & Acquisitions
Products & Services of MediPharm Labs
MediPharm Labs offers a comprehensive portfolio of products and services, including GMP Cannabis API, Formulated Oils, Capsules, and Vapes.
Provides bulk wholesale cannabis active pharmaceutical ingredients for medical use.
Offers oil-based cannabinoid extracts for consumption and wellness.
Delivers precisely dosed cannabinoid capsules for patient needs.
Produces inhalable cannabinoid products for quick absorption.
Apps and channels of MediPharm Labs
its YouTube channel MediPharm Labs TSX:LABS has 355 subscribers and 22 videos.
Videos from MediPharm Labs
The most watched videos on MediPharm Labs's YouTube channel, MediPharm Labs TSX:LABS (355 subscribers). Click a video to play it here.
More on MediPharm Labs TSX:LABS.
Funding Insights of MediPharm Labs
- Total Rounds 6
- Last Round Grant — $239,187
- First Round $3.8M
(Jul 2018)
- Investors Count 2
All 6 funding rounds of MediPharm Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | $239,187 | Grant | – | – | |
| Mar 2021 | $33M | Post-IPO | – | – | – |
| Jun 2020 | $28.18M | Post-IPO | – | – | – |
| Oct 2019 | $38.7M | Debt – Conventional | – | – | – |
| Jun 2019 | $55.9M | Post-IPO | – | – | – |
| Jul 2018 | $3.8M | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in MediPharm Labs
MediPharm Labs has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include business.gov.au and MMJ Group Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support is provided for businesses in Australia through government resources. | business.gov.au | Australia | ||
| mmjgh.com.au |
Investor details for MediPharm Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MediPharm Labs
34 people are tracked at MediPharm Labs (18 in leadership, 16 in team); the tracked headcount is 161.
| Name | Role | Group |
|---|---|---|
Keith Strachan | Co-Founder & President | Leadership |
Bill Gordon | Director of Information Technology | Leadership |
Laura Lepore | Vice President, Investor Relations & Communications | Leadership |
Saravan Subramaniam | Senior Director, Project Management Office and Facilities | Leadership |
Jake Golding | Director of Operations, Asia Pacific | Leadership |
Greg Hunter | Chief Financial Officer | Leadership |
Chris Talpas | Vice President, Quality and Scientific Affairs | Leadership |
Scarlett Gonzalez | Director of New Product Commercialization | Leadership |
Anuja Siwakoti | Director of Global Regulatory and Scientific Affairs | Leadership |
Nigel Dewsbury | Head of Quality | Leadership |
Kirk Binns | Executive Vice President, Global Accounts | Leadership |
George Polimenakos | Head Of Beacon Medical Australia | Leadership |
William Gordon (Bill) | Director Of Information Technology | Leadership |
Alison Belot | Vice President Sales And Marketing | Leadership |
Sarah McCutcheon | Director - International Commercial | Leadership |
Ahmed Shehata | General Counsel and Head of Corporate Development | Leadership |
Grant Ferguson | Vice President, Global Business Development & Partnerships | Leadership |
Darren Parker | Director of Facility Operations | Leadership |
Tait Gale | Manager of Research and Development | Team |
Don Courtemanche | Supply Chain Manager | Team |
14 more people are available in the full profile.
Complete people profiles for MediPharm Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of MediPharm Labs
MediPharm Labs is a publicly listed company on the TSX with ticker symbol LABS in Canada, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Jul 2019
- Listed onTSX: LABS
- Listed entityMediPharm Labs Corp.
- Exchange sectorProcess industries
- ISINCA58504D1006
- Share price0.07 CAD · 2026-10-13
- Market capitalisation29,902,401.00 CAD
- EPS (diluted, trailing year)-0.01 CAD
- Volume (last session)207,417
Financials of MediPharm Labs
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 45.1M CAD | -8.3M CAD | -7.0M CAD |
| 2024 | 42.0M CAD | -10.7M CAD | -9.1M CAD |
| 2023 | 33.1M CAD | -13.1M CAD | -16.4M CAD |
| 2022 | 22.1M CAD | -30.0M CAD | -25.8M CAD |
| 2021 | 21.7M CAD | -54.8M CAD | -42.2M CAD |
Detailed financial statements for MediPharm Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MediPharm Labs
MediPharm Labs has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include VIVO Cannabis.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Health-based cannabis products are manufactured for medical use. | vivocannabis.com | Greater Napanee, Canada | 2012 | Apr 2023 | •••• |
Complete acquisition details for MediPharm Labs
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MediPharm Labs
5 dated milestones of MediPharm Labs across 7 years, from founding to its latest funding, stage changes and deals.
- Founded MediPharm Labs is founded.
- Funding First funding round of $3.8M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $239K.
- Acquisition Acquires VIVO Cannabis.
Competitors of MediPharm Labs
MediPharm Labs has 2 listed competitors in our database, 1 of them funded. They include Motif Labs and Biotii Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| motiflabs.ca | 2017 | Aylmer, Canada | Cannabinoid extraction, purification, and formulation services are provided. | |||
| biotii.com | 2018 | Vancouver, Canada | $1.2M | Produces a portfolio of high-quality cannabis products. |
Detailed competitors of MediPharm Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MediPharm Labs
The website of MediPharm Labs (medipharmlabs.com) receives about 9.2K visits a month.
- Monthly visits9.2K
▲ 86.3% vs previous month
Top companies in Cannabis Health Tech Ecosystem
2 companies that operate in the same segment as MediPharm Labs (Cannabis Health Tech Ecosystem) in Canada, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | USD 204.24 M | 960 | ||
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | USD 186.16 M | 898 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medipharm Labs
Complete news archive for MediPharm Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MediPharm Labs
MediPharm Labs was founded in 2016 and raised its 1st funding round 2 years after it was founded.
MediPharm Labs is headquartered in Barrie, Canada. It is registered at Barrie, Ontario, Canada.
MediPharm Labs has 161 employees.
Annual revenue of MediPharm Labs is $32.95M as on Dec 31, 2025.
MediPharm Labs was founded in 2016 in Barrie, Canada, and operates within the pharmaceutical sector. Cannabinoid-based products and active pharmaceutical ingredients are formulated, tested, processed, packaged, and distributed to domestic and international markets. Wholesale products are supplied, while clinical trials and academic partnerships are supported. Extraction and purification methods are employed to produce high-quality cannabinoid derivatives.
MediPharm Labs's top competitors include Motif Labs and Biotii Technologies.
MediPharm Labs offers GMP Cannabis API, Formulated Oils, Capsules, and Vapes.
Yes, MediPharm Labs is publicly traded on TSX under the ticker symbol LABS.
MediPharm Labs has made 1 acquisition, including VIVO Cannabis.
MediPharm Labs has 2 investors. Key investors include business.gov.au, and MMJ Group Holdings.
MediPharm Labs operates through Medipharm Labs Inc..